Clinical efficacy, safety and inhibition of joint destruction of adalimumab in the treatment of moderate to severe psoriatic arthritis: 48-week results of the ADEPT trial

被引：0
|
作者：
Mease, P
Gladman, D
Ritchlin, C
Weinberg, M
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：AB214 / AB214
页数：1
相关论文
共 50 条
  • [41] EFFICACY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PSORIATIC ARTHRITIS (PSA) PATIENTS WITH AND WITHOUT MODERATE-TO-SEVERE PSORIASIS: 52-WEEK RESULTS FROM A MULTICENTRE, RANDOMIZED OPEN-LABEL STUDY
    Kristensen, Lars-Erik
    Okada, Masato
    Tillett, William
    Leage, Soyi Liu
    El Baou, Celine
    Bradley, Andrew
    Moszaros, Gabriella
    De Vlam, Kurt
    Mora Alfonso, Sergio Alexander
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S140 - S141
  • [42] Efficacy of Ixekizumab Versus Adalimumab in Psoriatic Arthritis ( PsA) Patients With and Without Moderate-to- Severe Psoriasis: 52-Week Results from a Multicentre, Randomised Open-Label Study
    Kristensen, Lars-Erik
    Okada, Masato
    Tillett, William
    Liu-Leage, Soyi
    El Baou, Celine
    Bradley, Andrew
    de Vlam, Kurt
    Dutz, Jan
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1167 - 1168
  • [43] Efficacy of adalimumab (Humira®) in Canadian clinical practice:: Subanalysis of the canact trial for patients with moderate vs. severe rheumatoid arthritis
    Keystone, Edward C.
    Stewart, Jackie
    Cividino, Alfred
    Haraoui, Paul
    Guerette, Benoit
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1605 - 1605
  • [44] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients
    Nishimura, Kenichi
    Hara, Ryoki
    Umebayashi, Hiroaki
    Takei, Syuji
    Iwata, Naomi
    Imagawa, Tomoyuki
    Shimizu, Masaki
    Tomiita, Minako
    Seko, Noriko
    Kitawaki, Tetsuji
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2021, 31 (01) : 226 - 234
  • [45] Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients Week 48 Results of the ARIEL Trial
    Violari, Avy
    Bologna, Rosa
    Kumarasamy, Nagalingeswaran
    Pilotto, Jose Henrique
    Hendrickx, Annemie
    Kakuda, Thomas N.
    Lathouwers, Erkki
    Opsomer, Magda
    Van de Casteele, Tom
    Tomaka, Frank L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (05) : E132 - E137
  • [46] Bimekizumab Treatment Is Associated with Improvements in Back Pain and Fatigue in Patients with Active Psoriatic Arthritis: 48-Week Results from a Phase 2b Study
    Deodhar, Atul
    Gossec, Laure
    Mease, Philip
    Coarse, Jason
    Edens, Heather
    De Peyrecave, Natasha
    Assudani, Deepak
    Ink, Barbara
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [47] Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
    Suh, Chang-Hee
    Yoo, Dae Hyun
    Berrocal Kasay, Alfredo
    Chalouhi El-Khouri, Elia
    Cons Molina, Francisco Fidenci
    Shesternya, Pavel
    Miranda, Pedro
    Medina-Rodriguez, Francisco G.
    Wiland, Piotr
    Jeka, Slawomir
    Chavez-Corrales, Jose
    Linde, Thomas
    Hrycaj, Pawel
    Abello-Banfi, Mauricio
    Hospodarskyy, Ihor
    Jaworski, Janusz
    Piotrowski, Mariusz
    Brzosko, Marek
    Krogulec, Marek
    Shevchuk, Sergii
    Calvo, Armando
    Andersone, Daina
    Park, Won
    Shim, Seung Cheol
    Lee, Sang Joon
    Lee, Sung Young
    BIODRUGS, 2019, 33 (01) : 79 - 91
  • [48] Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
    Chang-Hee Suh
    Dae Hyun Yoo
    Alfredo Berrocal Kasay
    Elia Chalouhi El-Khouri
    Francisco Fidenci Cons Molina
    Pavel Shesternya
    Pedro Miranda
    Francisco G. Medina-Rodriguez
    Piotr Wiland
    Slawomir Jeka
    Jose Chavez-Corrales
    Thomas Linde
    Pawel Hrycaj
    Mauricio Abello-Banfi
    Ihor Hospodarskyy
    Janusz Jaworski
    Mariusz Piotrowski
    Marek Brzosko
    Marek Krogulec
    Sergii Shevchuk
    Armando Calvo
    Daina Andersone
    Won Park
    Seung Cheol Shim
    Sang Joon Lee
    Sung Young Lee
    BioDrugs, 2019, 33 : 79 - 91
  • [49] Adalimumab or Cyclosporine as Monotherapy and in Combination in Severe Psoriatic Arthritis: Results from a Prospective 12-month Nonrandomized Unblinded Clinical Trial
    Karanikolas, George N.
    Koukli, Eftyhia-Maria
    Katsalira, Aikaterini
    Arida, Aikaterini
    Petrou, Dimitrios
    Komninou, Eleni
    Fragiadaki, Kalliopi
    Zacharioudaki, Anna
    Lasithiotakis, Ioannis
    Giavri, Eirini
    Vaiopoulos, George
    Sfikakis, Petros P.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2466 - 2474
  • [50] Effect of folic and folinic acid suppletion on toxicity and efficacy of methotrexate in rheumatoid arthritis: A randomized, double-blind, 48-week, clinical trial.
    Van Ede, A
    Laan, R
    Rood, M
    Huizinga, T
    Van De Laar, M
    Van Denderen, J
    Westgeest, A
    Romme, A
    De Rooij, DJ
    Jacobs, M
    De Boo, T
    Dijkmans, B
    Breedveld, F
    Van De Putte, L
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S380 - S380
12345